Neuroprotective strategies for retinal disease

Area of Science:

• Ophthalmology and Neuroscience

Background:

• Retinal diseases like diabetic retinopathy and glaucoma cause significant vision loss in millions.
• Current treatments are limited, highlighting the need for novel therapeutic approaches.
• Vision loss impacts quality of life and incurs substantial economic costs.

Purpose of the Study:

• To review promising neuroprotective strategies for preventing retinal cell death and vision loss.
• To focus on therapies with direct laboratory experience, including drugs and rehabilitative methods.
• To discuss the potential mechanisms, research findings, and clinical translation of these strategies.

Main Methods:

• Review of scientific literature on neuroprotective agents and rehabilitative therapies.
• Focus on specific drug classes: bile acids (UDCA, TUDCA), progesterone, retinal dopamine therapies, and neurotrophic factors.
• Inclusion of exercise and electrical stimulation as rehabilitative approaches.

Main Results:

• Several neuroprotective drugs targeting survival pathways show promise.
• Rehabilitative methods like exercise and electrical stimulation may enhance endogenous repair.
• Research in animal models and human studies provides evidence for these approaches.

Conclusions:

• Promising neuroprotective treatments exist for various retinal diseases.
• Further research is needed to translate these strategies into clinical practice.
• Targeting neuronal survival pathways offers hope for preventing blindness.